These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33926250)

  • 1. Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates.
    Kouta A; Jeske W; Cera L; Farshid A; Duff R; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2021; 27():10760296211005544. PubMed ID: 33926250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates.
    Kouta A; Hoppensteadt D; Bontekoe E; Jeske W; Duff R; Cera L; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620951851. PubMed ID: 33034200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
    Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
    Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
    [No Abstract]   [Full Text] [Related]  

  • 4. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
    Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
    Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels.
    Jeske W; Kouta A; Farooqui A; Siddiqui F; Rangnekar V; Niverthi M; Laddu R; Hoppensteadt D; Iqbal O; Walenga J; Fareed J
    Front Med (Lausanne); 2018; 5():360. PubMed ID: 30687709
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.
    Lewis J; Iqbal O; Jeske W; Hoppensteadt D; Siddiqui F; Fareed J
    Clin Appl Thromb Hemost; 2022; 28():10760296221099934. PubMed ID: 35535398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
    Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
    Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine.
    Glauser BF; Santos GRC; Silva JD; Tovar AMF; Pereira MS; Vilanova E; Mourão PAS
    J Thromb Haemost; 2018 Sep; 16(9):1789-1799. PubMed ID: 29968421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
    Kuziej J; Litinas E; Hoppensteadt DA; Liu D; Walenga JM; Fareed J; Jeske W
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):377-86. PubMed ID: 20460347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of enoxaparine-induced bleeding by protamine sulfate.
    Van Ryn-McKenna J; Cai L; Ofosu FA; Hirsh J; Buchanan MR
    Thromb Haemost; 1990 Apr; 63(2):271-4. PubMed ID: 2163553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I.
    Demir M; Iqbal O; Dietrich CP; Hoppensteadt DA; Ahmad S; Daud AN; Fareed J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):44-52. PubMed ID: 11190904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers.
    Holst J; Lindblad B; Bergqvist D; Garre K; Nielsen H; Hedner U; Ostergaard PB
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):795-803. PubMed ID: 7865687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profile.
    Fareed J; Hoppensteadt D; Schultz C; Ma Q; Kujawski MF; Neville B; Messmore H
    Curr Pharm Des; 2004; 10(9):983-99. PubMed ID: 15078128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate.
    Hogwood J; Mulloy B; Gray E
    Pharmaceuticals (Basel); 2017 Jul; 10(3):. PubMed ID: 28671597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
    Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
    Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
    Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
    Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation.
    Xie S; Guan Y; Zhu P; Li F; Yu M; Linhardt RJ; Chi L; Jin L
    Carbohydr Polym; 2018 Oct; 197():83-91. PubMed ID: 30007661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caltrop-like Small-Molecule Antidotes That Neutralize Unfractionated Heparin and Low-Molecular-Weight Heparin In Vivo.
    Zong Y; Lei Z; Yu SB; Zhang LY; Wu Y; Feng K; Qi QY; Liu Y; Zhu Y; Guo P; Zhou W; Zhang DW; Li ZT
    J Med Chem; 2024 Mar; 67(5):3860-3873. PubMed ID: 38407934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparins: differences and similarities in approved preparations in the United States.
    Bick RL; Fareed J
    Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S63-6. PubMed ID: 10726038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.